MARY NAGLE: Open Payments
NPI 1518253848 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 49 payments from 16 companies in 2025. Trend: 2023 $637 · 2024 $683 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $199 |
| PFIZER INC. | 8 | $142 |
| GlaxoSmithKline, LLC. | 3 | $105 |
| Kite Pharma, Inc. | 1 | $104 |
| ABBVIE INC. | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Amgen Inc. | 4 | $65 |
| Exact Sciences Corporation | 3 | $63 |
| Medtronic, Inc. | 3 | $62 |
| Astellas Pharma US Inc | 2 | $48 |
Products named: Yescarta, Ozempic, UBRELVY, AREXVY, PREVNAR 20, EVENITY, Cologuard Collection Kit, Wegovy.
Industry payments across ID — which companies pay providers there.
